fullerene c60 has been researched along with Adenocarcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corr, SJ; Curley, SA; Dilliard, S; Krzykawska-Serda, M; Lapin, NA; Mackeyev, Y; Serda, M; Wilson, LJ | 1 |
| Curley, SA; Dilliard, SA; Lapin, NA; Mackeyev, Y; Newton, JM; Serda, RE; Vergara, LA; Wilson, LJ | 1 |
| Anderson, AO; Corr, SJ; Curley, SA; Krzykawska-Serda, M; Law, J; Newton, JM; Nguyen, L; Sachdeva, S; Serda, M; Ware, MJ; Wilson, LJ | 1 |
| Chen, C; Fu, PP; Gao, X; Lao, F; Liang, XJ; Meng, J; Sun, B; Wang, PC; Xing, G; Yin, JJ; Zhao, Y | 1 |
| Brown, AP; Chung, EJ; Citrin, DE; Mitchell, JB; Shankavaram, UT; Shield, WP; Sowers, AL; Thetford, A; Urick, ME | 1 |
| Asanuma, D; Dai, T; Hamblin, MR; Huang, YY; Khan, UJ; Konopko, A; Mroz, P; Sharma, SK; Wharton, T; Xia, Y; Zhiyentayev, T | 1 |
6 other study(ies) available for fullerene c60 and Adenocarcinoma
| Article | Year |
|---|---|
The effects of non-invasive radiofrequency electric field hyperthermia on biotransport and biodistribution of fluorescent [60]fullerene derivative in a murine orthotopic model of breast adenocarcinoma.
Topics: Adenocarcinoma; Animals; Biological Transport; Cell Line, Tumor; Combined Modality Therapy; Drug Delivery Systems; Female; Fullerenes; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Mice, Nude; Tissue Distribution | 2017 |
Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma.
Topics: Adenocarcinoma; Animals; Drug Delivery Systems; Dynamic Light Scattering; Female; Fluorescence; Fullerenes; Intravital Microscopy; Kinetics; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Molecular Imaging; Nanoparticles; Solubility; Tissue Distribution; Water | 2017 |
Development of photoactive Sweet-C
Topics: Adenocarcinoma; Antibodies; Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cell- and Tissue-Based Therapy; Fullerenes; Glycoconjugates; Humans; Pancreatic Neoplasms; Pancreatic Stellate Cells; Photochemotherapy; Photosensitizing Agents | 2018 |
Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Humans; Lipid Peroxidation; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Evaluation of the fullerene compound DF-1 as a radiation protector.
Topics: Adenocarcinoma; Animals; Bone Marrow; Cells, Cultured; Fibroblasts; Fullerenes; Humans; Hypoxia; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Pancreatic Neoplasms; Prostatic Neoplasms; Radiation Injuries; Radiation-Protective Agents; Whole-Body Irradiation | 2010 |
Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma.
Topics: Abdomen; Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Fullerenes; Humans; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Micelles; Peritoneum; Photochemotherapy; Photosensitizing Agents; Pyrrolidines | 2011 |